Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride…
DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres®…